CBD Market in the US Expected to Reach $20.4 Billion by 2023

Mar.04.2023
CBD Market in the US Expected to Reach $20.4 Billion by 2023
This article is about the growth of the CBD industry in the US market and its potential global impact.

Statement:


This article is limited to conducting research on the related industries and overseas markets, and does not make recommendations for any products or provide comments on any domestic policies.


The legality of the products mentioned in the article is only limited to overseas areas. Domestic readers are advised to take note and strictly comply with relevant laws and regulations of China.


This article does not constitute any investment or consumer advice.


This article is not suitable for minors to read.


On the morning of March 3rd, Eastern Time, two employees from the Washington News Center of 2FIRSTS interviewed Caesar, their marketing manager, at the APE exhibition. Caesar stated that the CBD market in the United States is expected to reach $20.4 billion by 2023.


During an interview with 2FIRSTS, Caesar revealed that APE has noticed a significant increase in sales of CBD products at recent exhibitions. He noted that compared to the tobacco industry and other related industries, the growth in CBD sales is much more substantial. It is projected that the CBD market in the United States will reach $20.4 billion by the year 2023, as stated by Caesar.


Caesar stated that the use of CBD is becoming increasingly widespread. Currently, many companies have started to incorporate CBD in food and drink products, such as butter, oil, or other grains.


Caesar announced that their next exhibition will be held in Medellin, South America. Over 90% of the exhibition spaces have already been sold. The exhibition in Dallas, USA, sold out 70% of its spaces within five months after the show.


Furthermore, Caesar told 2FIRSTS that APE was formerly known as the USA CBD Expo, but due to the growth of e-cigarettes, the USA CBD Expo had to add e-cigarette categories, thus evolving into the Alternative Products Expo.


Further reading:


The media company 2FIRSTS has been named the official partner of the APE Expo, a tobacco trade show in the United States. As a result, they will provide comprehensive coverage of the event.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

New York Nicotine Pouch Tax Moves Forward as Critics Question Public Health Impact
New York Nicotine Pouch Tax Moves Forward as Critics Question Public Health Impact
New York Governor Kathy Hochul included in her FY 2027 budget proposal a plan to impose the same 75% wholesale tax on nicotine pouches such as Zyn that applies to cigarettes. The measure is expected to raise USD 18 million in FY 2027 and USD 44 million in FY 2028 after full implementation.
Mar.30 by 2FIRSTS.ai
New Movement Emerges on EU Tobacco Excise Directive as Cyprus Tables Compromise Draft
New Movement Emerges on EU Tobacco Excise Directive as Cyprus Tables Compromise Draft
The long-stalled debate over the European Union’s Tobacco Excise Directive may be moving forward, with Cyprus, as holder of the EU Council presidency, putting forward a compromise draft. The reported proposal includes lowering the minimum excise duty requirement and granting a transitional period, with the aim of reaching political agreement by June 2026. The revision also covers e-cigarettes, heated tobacco, nicotine pouches and stronger controls on raw tobacco.
Apr.21 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
China’s e-cigarette export value declined to $694 million in April 2026, marking the lowest April level in the past three years. The data is notable because April was the first full month after China removed export VAT rebates for certain e-cigarette products. Compared with April 2025, export value fell 20.9%; compared with April 2024, it was down 22.3%. Month-on-month, exports dropped 23.2% from March 2026.
Special Report
May.23
Moscow Police Seize About 65,000 E-Cigarettes Worth More Than RUB 30 Million
Moscow Police Seize About 65,000 E-Cigarettes Worth More Than RUB 30 Million
Russian Interior Ministry spokesperson Irina Volk said on May 6 that police in Moscow seized about 65,000 nicotine-containing products from a man during searches of residential and warehouse premises. The products were valued at about RUB 30 million, or about USD 395,727 based on an exchange rate of USD 1 = RUB 75.81.
May.11 by 2FIRSTS.ai
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12